Research

Hormonal

Metabolic bariatric surgery leads to sustained HbA1c reduction, whereas non-surgical management is associated with HbA1c increase in patients with type 2 diabetes.

For patients with severe obesity and type 2 diabetes, metabolic bariatric surgery offers significantly better long-term weight loss and blood sugar control than non-surgical management. While surgery is not for everyone, those who undergo it maintain much greater weight loss (22% vs 8.6%) and better glycemic control over five years. If surgery is not an option, intensive lifestyle modification and pharmacotherapy are critical alternatives to mitigate health risks.

GoodSupportsHIGH confidence
HbA1c decreased by 1.0% (95% CI: −1.31, −0.70) in the surgery group but increased by 0.4% (95% CI: 0.09, 0.71) in the non-surgery group.
Beatrice J. Leyaro et al. · International Journal of Obesity · 2025

Why this rating

Retrospective cohort study with real-world data, large sample size, and 5-year follow-up.

Source

Metabolic bariatric surgery pays off: a longitudinal analysis of weight loss and HbA1c changes in real-world patients data in the West of Scotland

Beatrice J. Leyaro et al. · International Journal of Obesity · 2025

DOI 10.1038/s41366-025-01956-6

cohort · n=411
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →